In a report released today, Ronald Kamdem from Morgan Stanley maintained a Buy rating on Healthpeak Properties (DOC – Research Report), with a price target of $24.00. The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback